People on insulin living next to roads with heavy traffic had markedly increased concentration of C-reactive protein, a marker of inflammation, compared to those living in lower traffic areas, a two-year epidemiological study has found. Individuals taking oral diabetes medications did not experience increases in CRP concentration.